On Tuesday, DR Horton Inc. (NYSE:DHI)’s shares declined -2.37%, and closed at $28.03, as the corporation will release financial results for its second fiscal quarter ended March 31, 2015 on Wednesday, April 22, 2015 before the market opens. The Corporation will host a conference call that morning at 10:00 a.m. Eastern Time (ET). The dial-in number is 877-407-8033. Participants are encouraged to call in five minutes before the call starts (9:55 a.m. ET). The call will also be webcast from the Corporation’s website at investor.drhorton.com.
D.R. Horton, Inc. operates as a homebuilding corporation. It is engaged in the attainment and development of land; and construction and sale of residential homes in 27 states and 79 markets in the United States under the names of D.R. Horton, America’s Builder, Express Homes, Emerald Homes, Breland Homes, Regent Homes, and Crown Communities.
AuRico Gold Inc. (NYSE:AUQ)’s shares dropped -2.33%, and settled at $2.93, during the last trading session on Tuesday, as on March 31, a gold producer with mines and projects in North America, declared that it will release the Corporation’s first quarter financial results for the period ended March 31, 2015 after market close on Wednesday, May 6, 2015. The financial statements will be accessible on the Corporation’s website at www.auricogold.com or www.sedar.com. Additionally, the Corporation will host its Annual General and Special Meeting on Thursday, May 7, 2015.
AuRico Gold Inc. operates as a gold producer with mines and projects in North America. Its principal projects comprise the Young-Davidson gold mine compriseing of contiguous mineral leases and claims totaling 11,000 acres located in Northern Ontario, Canada; and the El Chanate mine comprising 22 mineral concessions that cover an area of about 4,618 hectares located in Sonora State, Mexico.
At the end of Tuesday’s trade, Telefónica, S.A. (NYSE:TEF)’s shares dipped -2.31%, and closed at $14.37, after Accenture (ACN) and Alcatel-Lucent (NYSE: ALU) have declared a four-year contract with Telefónica to deploy Alcatel-Lucent’s Motive Customer Experience Administration software for Telefónica residential customers in European and Latin American countries. As a result, customers will gain more control over their broadband experience, counting self-assist tools to reduce calls to customer care and shorten resolution times.
The contract results from the planned alliance formed by Alcatel-Lucent and Accenture in September 2014 to assist communications service providers (CSPs) and large enterprises implement integrated ultra-broadband solutions to address the challenges of rising costs and raised data consumption caused by high demand from digital customers and applications. Through a combination of Alcatel-Lucent’s CEM products and Accenture’s systems integration and transformation capabilities, Telefónica will expand the capabilities of its customer care centers.
As part of Telefónica’s strategy to simplify its processes and platforms, this transformation will provide Telefónica personnel with greater visibility of the network, in addition to new tools for agent-assisted, consumer self-assist, field technician-assisted and proactive customer care to enhance customer service to more than 100 million subscribers.
Together, Accenture and Alcatel-Lucent will enable Telefónica to improve the end-to-end customer experience across mobile data, mobile voice, IPTV, high-speed Internet, cable, satellite and voice services, allowing Telefónica’s customers to troubleshoot and manage their digital experiences through devices such as mobile phones, laptops and IP set-top boxes, via Telefónica web portal and apps.
Telefónica, S.A. provides fixed and mobile communication services primarily in Europe and Latin America. The corporation offers mobile voice, value added, mobile data and Internet, wholesale, corporate, roaming, fixed wireless, and trunking and paging services. It offers fixed telecommunication services, counting PSTN lines; ISDN accesses; public telephone; local, domestic, and international long distance and fixed-to-mobile communications; corporate communications; supplementary and business oriented value-added; video telephony; intelligent network; and telephony information services, in addition to leases and sells handset equipment.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), ended its Tuesday’s trading session with -2.15% loss, and closed at $0.93, as a biopharmaceutical corporation focused on developing breakthrough treatments for human disease, will visit the NASDAQ MarketSite in Times Square.
In honor of the occasion, Lonnel Coats, President and Chief Executive Officer will ring the Closing Bell.
NASDAQ MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio, on Wednesday, April 8, 2015 – 3:45 p.m. to 4:00 p.m. ET.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical corporation, focuses on the discovery and development of pharmaceutical products for the treatment of human diseases. Its drug development programs comprise telotristat etiprate, an orally-delivered small molecule drug candidate, which is in Phase III clinical trials for the treatment of carcinoid syndrome.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
